Inovio Pharmaceuticals Inc
NASDAQ:INO

Watchlist Manager
Inovio Pharmaceuticals Inc Logo
Inovio Pharmaceuticals Inc
NASDAQ:INO
Watchlist
Price: 2.27 USD -4.22%
Market Cap: 155.9m USD

Wall Street
Price Targets

INO Price Targets Summary
Inovio Pharmaceuticals Inc

Wall Street analysts forecast INO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for INO is 7.79 USD with a low forecast of 1.82 USD and a high forecast of 13.65 USD.

Lowest
Price Target
1.82 USD
20% Downside
Average
Price Target
7.79 USD
243% Upside
Highest
Price Target
13.65 USD
501% Upside
Inovio Pharmaceuticals Inc Competitors:
Price Targets
CNTB
Connect Biopharma Holdings Ltd
250% Upside
RARE
Ultragenyx Pharmaceutical Inc
150% Upside
VNDA
Vanda Pharmaceuticals Inc
73% Upside
RNA
Avidity Biosciences Inc
3% Upside
GBIO
Generation Bio Co
475% Upside
ANAB
AnaptysBio Inc
29% Upside
IPH
Innate Pharma SA
222% Upside
301080
Acrobiosystems Co Ltd
42% Upside

Revenue
Forecast

Revenue Estimate
Inovio Pharmaceuticals Inc

For the last 13 years the compound annual growth rate for Inovio Pharmaceuticals Inc's revenue is -25%. The projected CAGR for the next 4 years is 439%.

-25%
Past Growth
439%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Inovio Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Inovio Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-89%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is INO's stock price target?
Price Target
7.79 USD

According to Wall Street analysts, the average 1-year price target for INO is 7.79 USD with a low forecast of 1.82 USD and a high forecast of 13.65 USD.

What is Inovio Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
439%

For the last 13 years the compound annual growth rate for Inovio Pharmaceuticals Inc's revenue is -25%. The projected CAGR for the next 4 years is 439%.

Back to Top